BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Syntonix Pharmaceuticals, Inc. 

9 Fourth Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-547-6000 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Zenobia Therapeutics, Inc. Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals, Inc. 4/14/2009 9:10:51 AM    More...
Biovitrum AB's and Syntonix Pharmaceuticals, Inc.'s Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA 11/24/2008 10:09:24 AM    More...
Biovitrum AB and Syntonix Pharmaceuticals, Inc. Dose First Hemophilia B Patient in Clinical Trial of a Novel Factor IXFc Treatment 5/27/2008 2:40:37 PM    More...
Biovitrum AB and Syntonix Pharmaceuticals, Inc. Dose First Hemophilia B Patient in Clinical Trial of a Novel Factor IXFc Treatment 5/27/2008 9:26:21 AM    More...
Biovitrum AB and Syntonix Pharmaceuticals, Inc. Set to Begin Phase I/IIa Clinical Trial 3/4/2008 7:08:50 AM    More...
The Day In Review: Schering-Plough Corporation (SGP) Gets Approval For Noxafil 9/18/2006 5:11:23 PM    More...
Serono International S.A. (SRA) And Syntonix Pharmaceuticals, Inc. To Pursue The Development Of A Long-Acting, Inhaleable FSH Therapy To Treat Infertility 9/18/2006 1:07:18 PM    More...
Biovitrum AB And Syntonix Pharmaceuticals, Inc. Enter Agreement For The Joint Development And Commercialization Of Recombinant Factor IX For The Treatment Of Hemophilia 1/23/2006 11:41:22 AM    More...
Syntonix Pharmaceuticals, Inc. And Boehringer Ingelheim Corporation Enter Collaboration For Up To $63 Million To Optimize Therapeutic 10/21/2005 11:02:55 AM    More...
Serono International S.A. (SRA) And Syntonix Pharmaceuticals, Inc. Sign Worldwide Agreement To Develop And Commercialize An Inhaleable Interferon-Beta Therapy For Multiple Sclerosis 10/19/2005 5:13:10 PM    More...
12

//-->